• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Atherosclerosis.动脉粥样硬化
Nature. 2000 Sep 14;407(6801):233-41. doi: 10.1038/35025203.
2
Role of platelets in the pathophysiology of acute coronary syndrome.血小板在急性冠状动脉综合征病理生理学中的作用。
Semin Vasc Med. 2003 May;3(2):147-62. doi: 10.1055/s-2003-40673.
3
[Fundamental data on atherosclerosis].[动脉粥样硬化的基础数据]
Ann Endocrinol (Paris). 2001 Feb;62(1 Pt 2):93-100.
4
Molecular mechanisms involved in atherosclerosis.动脉粥样硬化涉及的分子机制。
Herz. 2002 Nov;27(7):637-48. doi: 10.1007/s00059-002-2431-2.
5
[From risk factors of arterial disease to atheroma plaque detection of the high-risk plaque].[从动脉疾病的危险因素到高危斑块的动脉粥样硬化斑块检测]
Rev Fac Cien Med Univ Nac Cordoba. 2004;61 Suppl 1:39-52.
6
Natural history and risk factors of atherosclerosis in children and youth: the PDAY study.儿童和青少年动脉粥样硬化的自然史及危险因素:PDAY研究。
Pediatr Pathol Mol Med. 2002 Mar-Apr;21(2):213-37. doi: 10.1080/15227950252852104.
7
Is there an infective aetiology to atherosclerosis?动脉粥样硬化是否存在感染性病因?
Drugs Aging. 1998 Jul;13(1):1-7. doi: 10.2165/00002512-199813010-00001.
8
Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae.动脉粥样硬化病因中的慢性感染——聚焦肺炎衣原体
Atherosclerosis. 1999 Mar;143(1):1-6. doi: 10.1016/s0021-9150(98)00317-7.
9
Atherosclerosis and coronary heart disease.动脉粥样硬化与冠心病
Br J Biomed Sci. 1993 Sep;50(3):235-48.
10
Ascorbic acid and atherosclerosis.抗坏血酸与动脉粥样硬化
Am J Clin Nutr. 1970 Jan;23(1):27-30. doi: 10.1093/ajcn/23.1.27.

引用本文的文献

1
Broad-spectrum therapeutic potential of 4-phenylbutyrate in neurological and systemic diseases of viral and non-viral origin.4-苯基丁酸在病毒源性和非病毒源性神经及全身性疾病中的广谱治疗潜力。
Front Pharmacol. 2025 Aug 21;16:1621590. doi: 10.3389/fphar.2025.1621590. eCollection 2025.
2
Identification of plasma lipid metabolism and potential biomarkers in patients with different coronary occlusive acute myocardial infarction.不同冠状动脉闭塞性急性心肌梗死患者血浆脂质代谢及潜在生物标志物的鉴定
Front Cell Dev Biol. 2025 Aug 14;13:1575431. doi: 10.3389/fcell.2025.1575431. eCollection 2025.
3
Twinkling Peptide Nanoemulsions Enable Precision Ultrasound Detection of Atherosclerotic Plaques.闪烁肽纳米乳剂实现动脉粥样硬化斑块的精准超声检测。
Adv Funct Mater. 2025 Feb 19;35(8). doi: 10.1002/adfm.202415609. Epub 2024 Dec 13.
4
Molecular Duality of OGG1: From Genomic Guardian to Redox-Sensitive Modulator in Diseases.OGG1的分子双重性:从基因组守护者到疾病中氧化还原敏感调节剂
Antioxidants (Basel). 2025 Aug 10;14(8):980. doi: 10.3390/antiox14080980.
5
Computed Tomography and Coronary Plaque Analysis.计算机断层扫描与冠状动脉斑块分析
Tomography. 2025 Jul 30;11(8):85. doi: 10.3390/tomography11080085.
6
Demystifying the nuances of the lipid patient: a guide for primary care providers.揭开血脂异常患者的细微差别:初级保健提供者指南
Am J Prev Cardiol. 2025 Jul 26;23:101070. doi: 10.1016/j.ajpc.2025.101070. eCollection 2025 Sep.
7
Engineering chimeric PCSK9 for a vaccine against atherosclerosis.工程化嵌合前蛋白转化酶枯草溶菌素9用于抗动脉粥样硬化疫苗的研发
Mol Ther Methods Clin Dev. 2025 Jul 12;33(3):101535. doi: 10.1016/j.omtm.2025.101535. eCollection 2025 Sep 11.
8
Membrane vesicles from Red Complex bacteria: key players in oral pathogenesis, immune disruption, systemic diseases, and therapeutic insights.红色复合体细菌的膜泡:口腔致病机制、免疫破坏、全身性疾病及治疗见解中的关键因素
Front Oral Health. 2025 Jul 28;6:1607931. doi: 10.3389/froh.2025.1607931. eCollection 2025.
9
The Role of SGLT2 Inhibitors in Atherosclerosis: A Systematic Review.钠-葡萄糖协同转运蛋白2抑制剂在动脉粥样硬化中的作用:一项系统评价
J Community Hosp Intern Med Perspect. 2025 Jul 3;15(4):29-33. doi: 10.55729/2000-9666.1505. eCollection 2025.
10
Current status and challenges of multi-omics research using animal models of atherosclerosis.使用动脉粥样硬化动物模型进行多组学研究的现状与挑战
J Mol Cell Cardiol Plus. 2025 Jul 10;13:100476. doi: 10.1016/j.jmccpl.2025.100476. eCollection 2025 Sep.

本文引用的文献

1
Activating mineralocorticoid receptor mutation in hypertension exacerbated by pregnancy.妊娠加剧的高血压中激活盐皮质激素受体突变
Science. 2000 Jul 7;289(5476):119-23. doi: 10.1126/science.289.5476.119.
2
Endothelial responses to oxidized lipoproteins determine genetic susceptibility to atherosclerosis in mice.内皮细胞对氧化脂蛋白的反应决定了小鼠动脉粥样硬化的遗传易感性。
Circulation. 2000 Jul 4;102(1):75-81. doi: 10.1161/01.cir.102.1.75.
3
Searching for genetic determinants in the new millennium.在新千年中寻找基因决定因素。
Nature. 2000 Jun 15;405(6788):847-56. doi: 10.1038/35015718.
4
Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.具有T15独特型的天然抗体可能在动脉粥样硬化、凋亡清除和保护性免疫中发挥作用。
J Clin Invest. 2000 Jun;105(12):1731-40. doi: 10.1172/JCI8472.
5
Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice.抑制CD40信号传导可限制小鼠已形成动脉粥样硬化的进展。
Proc Natl Acad Sci U S A. 2000 Jun 20;97(13):7458-63. doi: 10.1073/pnas.97.13.7458.
6
New target regions for human hypertension via comparative genomics.通过比较基因组学确定人类高血压的新靶点区域
Genome Res. 2000 Apr;10(4):473-82. doi: 10.1101/gr.10.4.473.
7
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species.巨噬细胞清道夫受体CD36是单核细胞产生的活性氮修饰的低密度脂蛋白的主要受体。
J Clin Invest. 2000 Apr;105(8):1095-108. doi: 10.1172/JCI8574.
8
Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice.对B类清道夫受体CD36进行靶向破坏可预防小鼠动脉粥样硬化病变的发展。
J Clin Invest. 2000 Apr;105(8):1049-56. doi: 10.1172/JCI9259.
9
Changing concepts of atherogenesis.动脉粥样硬化形成的概念变迁
J Intern Med. 2000 Mar;247(3):349-58. doi: 10.1046/j.1365-2796.2000.00654.x.
10
Combined serum paraoxonase knockout/apolipoprotein E knockout mice exhibit increased lipoprotein oxidation and atherosclerosis.血清对氧磷酶联合敲除/载脂蛋白E敲除小鼠表现出脂蛋白氧化增加和动脉粥样硬化。
J Biol Chem. 2000 Jun 9;275(23):17527-35. doi: 10.1074/jbc.M910376199.

动脉粥样硬化

Atherosclerosis.

作者信息

Lusis A J

机构信息

Department of Medicine, Biology Institute, University of California, Los Angeles 90095, USA.

出版信息

Nature. 2000 Sep 14;407(6801):233-41. doi: 10.1038/35025203.

DOI:10.1038/35025203
PMID:11001066
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2826222/
Abstract

Atherosclerosis, a disease of the large arteries, is the primary cause of heart disease and stroke. In westernized societies, it is the underlying cause of about 50% of all deaths. Epidemiological studies have revealed several important environmental and genetic risk factors associated with atherosclerosis. Progress in defining the cellular and molecular interactions involved, however, has been hindered by the disease's aetiological complexity. Over the past decade, the availability of new investigative tools, including genetically modified mouse models of disease, has resulted in a clearer understanding of the molecular mechanisms that connect altered cholesterol metabolism and other risk factors to the development of atherosclerotic plaque. It is now clear that atherosclerosis is not simply an inevitable degenerative consequence of ageing, but rather a chronic inflammatory condition that can be converted into an acute clinical event by plaque rupture and thrombosis.

摘要

动脉粥样硬化是一种发生于大动脉的疾病,是心脏病和中风的主要病因。在西方化社会中,它是约50%的所有死亡的潜在原因。流行病学研究已经揭示了与动脉粥样硬化相关的几个重要环境和遗传风险因素。然而,由于该疾病病因的复杂性,在确定所涉及的细胞和分子相互作用方面的进展受到了阻碍。在过去十年中,包括疾病的转基因小鼠模型在内的新研究工具的出现,使人们对将胆固醇代谢改变和其他风险因素与动脉粥样硬化斑块形成联系起来的分子机制有了更清晰的认识。现在很清楚,动脉粥样硬化不仅仅是衰老不可避免的退行性后果,而是一种慢性炎症状态,可因斑块破裂和血栓形成而转化为急性临床事件。